Peregrine Capital Management LLC lessened its stake in Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) by 7.0% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 275,134 shares of the company's stock after selling 20,589 shares during the period. Peregrine Capital Management LLC owned 0.84% of Bowhead Specialty worth $11,184,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bank of America Corp DE lifted its stake in shares of Bowhead Specialty by 113.3% in the 4th quarter. Bank of America Corp DE now owns 154,961 shares of the company's stock worth $5,504,000 after acquiring an additional 82,305 shares during the period. Charles Schwab Investment Management Inc. lifted its position in Bowhead Specialty by 18.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 77,337 shares of the company's stock valued at $2,747,000 after purchasing an additional 12,049 shares during the period. Cambridge Investment Research Advisors Inc. acquired a new stake in Bowhead Specialty in the first quarter valued at about $3,891,000. Gallatin Point Capital LLC purchased a new stake in Bowhead Specialty in the 4th quarter valued at approximately $389,599,000. Finally, JPMorgan Chase & Co. increased its position in Bowhead Specialty by 102.4% during the 4th quarter. JPMorgan Chase & Co. now owns 99,813 shares of the company's stock worth $3,545,000 after purchasing an additional 50,491 shares during the period.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on BOW. JPMorgan Chase & Co. lifted their price target on Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a research note on Tuesday, April 8th. Piper Sandler started coverage on shares of Bowhead Specialty in a research note on Wednesday, April 16th. They set an "overweight" rating and a $44.00 price target on the stock. JMP Securities increased their price target on shares of Bowhead Specialty from $38.00 to $40.00 and gave the company a "market outperform" rating in a report on Friday, April 11th. Keefe, Bruyette & Woods upped their target price on shares of Bowhead Specialty from $43.00 to $45.00 and gave the stock an "outperform" rating in a research report on Friday, May 9th. Finally, Morgan Stanley increased their target price on shares of Bowhead Specialty from $36.00 to $39.00 and gave the company an "equal weight" rating in a report on Monday, May 19th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $39.67.
Get Our Latest Research Report on BOW
Bowhead Specialty Trading Down 0.9%
Shares of NYSE:BOW traded down $0.31 during midday trading on Thursday, hitting $35.15. 106,010 shares of the stock were exchanged, compared to its average volume of 202,844. The stock has a market cap of $1.15 billion, a P/E ratio of 26.83 and a beta of -0.60. Bowhead Specialty Holdings Inc. has a twelve month low of $24.41 and a twelve month high of $42.29. The company has a 50 day moving average price of $37.79 and a 200-day moving average price of $36.07.
Bowhead Specialty (NYSE:BOW - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.33 by $0.01. Bowhead Specialty had a net margin of 9.32% and a return on equity of 12.52%. The company had revenue of $174.85 million during the quarter, compared to analysts' expectations of $105.17 million. On average, equities research analysts expect that Bowhead Specialty Holdings Inc. will post 1.36 earnings per share for the current year.
Bowhead Specialty Company Profile
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Read More

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.